Rochlin Kate reported INAB

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001898521-25-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 22, 2025

Published

Dec 23, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

Rochlin Kate

Role

Chief Operating Officer

Transaction

Grant or awardAs filed: “A”

Asset

IN8BIO, INC.

Ticker

INAB

Shares

7,247

Price per share

$1.38

Value

$10,001

Execution date (reported)

Dec 22, 2025

Owned after transaction

9,085 shares

Days from execution to publication

1

Calculation

What this establishes

Rochlin Kate filed this Form 4 reporting a grant or award of INAB on Dec 22, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Operating Officer

Rochlin Katecik:0001898521

Issuer

IN8BIO, INC.cik:0001740279

Revision history · 0

No field has changed since this record was first ingested.